Bevacizumab, a 149-kDa proteins, is a recombinant humanized monoclonal antibody to
Bevacizumab, a 149-kDa proteins, is a recombinant humanized monoclonal antibody to VEGF. shot with the mix of bevacizumab and p-PEDF-SAINT-18 effectively inhibited corneal NV. The bFGF and PEDF genes had been effectively expressed as proven by traditional western blot evaluation, and a light immune system response to HLA-DR was proven by immunohistochemistry. We figured the … [Read more…]